67514-07-2

Basic information

• Product Name: 3-(4-phenylpiperazin-1-yl)propan-1-ol
• CAS NO: 67514-07-2
• Molecular Formula: C₁₃H₂₀N₂O
• Molecular Weight: 220.3107
• Mol File: 67514-07-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 375°C at 760 mmHg
• Flash Point: 190.4°C
• Density: 1.078g/cm³
• Vapor Pressure: 2.74E-06mmHg at 25°C
• Refractive Index: 1.554
• CAS DataBase Reference: 3-(4-phenylpiperazin-1-yl)propan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-phenylpiperazin-1-yl)propan-1-ol(67514-07-2)
• EPA Substance Registry System: 3-(4-phenylpiperazin-1-yl)propan-1-ol(67514-07-2)

Safety Data

• Hazardous Substances Data: 67514-07-2(Hazardous Substances Data)

Usage

General Description

3-(4-phenylpiperazin-1-yl)propan-1-ol is a chemical compound derived from the combination of a piperazine, phenyl, and propan-1-ol groups. It is classified as a psychoactive drug due to its potential effects on the central nervous system. 3-(4-phenylpiperazin-1-yl)propan-1-ol is commonly used as an intermediate in the synthesis of pharmaceuticals such as antipsychotic and antidepressant medications. Additionally, it has been studied for its potential as a treatment for conditions such as anxiety and psychosis. 3-(4-phenylpiperazin-1-yl)propan-1-ol is also known to exhibit sedative and anxiolytic properties, making it a subject of interest in the field of medicinal chemistry. However, its use and distribution are heavily regulated due to its psychoactive nature and potential for abuse.

Upstream product

• 92-54-6 4-phenyl-1-piperazine 
• 107-18-6 allyl alcohol 
• 109-64-8 1,3-dibromo-propane 
• 56968-65-1 1-(2-ethoxycarbonylethyl)-4-phenyl-piperazine 
• 627-18-9 1-bromo-3-propanol 

Downstream Products

• 10599-17-4 1-(3-chloropropyl)-4-phenylpiperazine 
• 84344-48-9 4-[3-(4-phenylpiperazin-1-yl)propoxy]benzaldehyde 
• 84344-47-8 1-<4-formylphenoxy>-3-1-(N⁴-phenylpiperazinyl)>propane 
• 103074-81-3 2-{4-[3-(4-Phenyl-piperazin-1-yl)-propoxy]-phenyl}-thiazolidine-3-carbothioic acid methylamide 
• 103074-79-9 2-{3-[3-(4-Phenyl-piperazin-1-yl)-propoxy]-phenyl}-thiazolidine-3-carbothioic acid methylamide 
• 1262048-29-2 C₁₄H₂₂N₂O₃S 

Relevant articles and documents

Manganese-Catalyzed Anti-Markovnikov Hydroamination of Allyl Alcohols via Hydrogen-Borrowing Catalysis

Controlling the selectivity in a hydroamination reaction is an extremely challenging yet highly desirable task for the diversification of amines. In this article, a selective formal anti-Markovnikov hydroamination of allyl alcohols is presented. It enables the versatile synthesis of valuable γ-amino alcohol building blocks. A phosphine-free Earth's abundant manganese(I) complex catalyzed the reaction under hydrogen-borrowing conditions. A vast range of aliphatic, aromatic amines, drug molecules, and natural product derivatives underwent successful hydroamination with primary and secondary allylic alcohols with excellent functional group tolerance (57 examples). The catalysis could be performed on a gram scale and has been applied for the synthesis of drug molecules. The mechanistic studies revealed the metal-ligand bifunctionality as well as hemilability of the ligand backbone as the key design principle for the success of this catalysis.

A formal anti-Markovnikov hydroamination of allylic alcohols via tandem oxidation/1,4-conjugate addition/1,2-reduction using a Ru catalyst

A formal anti-Markovnikov hydroamination of allylic alcohols using a Ru catalyst via tandem oxidation/1,4-conjugate addition/1,2-reduction was developed. Thus, the reaction of allylic alcohols with amines was performed in the presence of the catalyst generated from RuClH(CO)(PPh3)3 and 2,6-bis(n-butyliminomethyl)pyridine in situ to afford the corresponding γ-amino alcohols efficiently. This journal is

Structure - Activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: Unexpected agonistic activity in a series of muscarinic antagonists

As a continuation of previous research on anticholinergic drugs derived from 2,2-diphenyl-2-ethylthioacetic acid, several 5,5-diphenyl-5-ethylthio-2-pentynamines (2-11) were synthetised and their antimuscarinic activity on M1-4 receptor subtypes was evaluated by functional tests and binding experiments. One of the compounds obtained showed unexpected agonistic activity in functional experiments on M2 receptors. Since the compound carried a phenylpiperazine moiety, other similar compounds (12-17) were prepared and found to be endowed with similar behaviour. These ligands, although possessing the bulky structure characterising muscarinic antagonists, display agonistic activity at M2 subtypes while, as expected, behaving as antagonists on M3 and M4 subtypes. On M1 subtypes, they show agonistic activity which, however, is not blocked by atropine. The peculiar pharmacological profile of these compounds is of interest for studying muscarinic receptor subtypes.